Loading...
XSHE
300247
Market cap439mUSD
Oct 09, Last price  
3.78CNY
1D
3.28%
1Q
1.89%
Jan 2017
-53.79%
IPO
-21.77%
Name

Youngy Health Co Ltd

Chart & performance

D1W1MN
XSHE:300247 chart
P/E
40.63
P/S
3.26
EPS
0.09
Div yield, %
—
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
12.13%
Revenues
933m
+35.48%
144,152,876170,547,068196,618,489207,351,491245,317,898265,046,558284,121,067429,219,403599,904,9771,218,055,6601,063,357,911730,153,383514,081,347526,501,936526,501,936463,318,978463,318,978529,447,501688,791,514933,150,483
Net income
75m
+59.65%
26,452,40535,815,73545,412,61046,477,49319,271,94916,213,02119,431,94940,837,12985,634,52867,708,148-782,170,134-716,058,363-65,728,87924,203,16124,203,163126,309,485126,309,48626,582,64546,854,04874,803,222
CFO
116m
+126.64%
7,074,63118,312,645052,731,88148,821,59929,748,436028,056,17520,527,000043,940,56505,556,981100,063,46480,965,34410,821,914-29,228,25188,411,72851,056,974115,716,141
Dividend
Jun 14, 20180.03 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Youngy Health Co., Ltd., established in 1995 and headquartered in Hefei, China, specializes in manufacturing and selling a diverse range of sauna equipment across China. Their product line features various sauna types, including infrared, traditional, foot, and portable steam and infrared options. Beyond saunas, the company also produces air purifiers, carbon heating painting products, functional sofas and chairs, Saunalux brand items, and SUP and boat-related products. Their sauna offerings are distributed globally, reaching approximately 70 countries.

Key people

Xiaodong Qian
General Manager, Staff Elected Director · since 2025
Hanzhou Xu
General Manager · since 2025
Jun Liang
Deputy General Manager · since 2025
Director · since 2023
Director · since 2025
Fenling Xing
Chairman of the Board, Acting Secretary of the Board · since 2025
Independent Director · since 2023
Independent Director · since 2022
IPO date
Jul 29, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT